date: 2014-07-28T07:29:01Z
pdf:PDFVersion: 1.7
pdf:docinfo:title: Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease
xmp:CreatorTool: Elsevier
access_permission:can_print_degraded: true
subject: YNICL, 3 (2013) 84-94. doi:10.1016/j.nicl.2013.07.005
dc:format: application/pdf; version=1.7
pdf:docinfo:custom:robots: noindex
pdf:docinfo:creator_tool: Elsevier
access_permission:fill_in_form: true
pdf:encrypted: false
dc:title: Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease
modified: 2014-07-28T07:29:01Z
cp:subject: YNICL, 3 (2013) 84-94. doi:10.1016/j.nicl.2013.07.005
robots: noindex
pdf:docinfo:custom:CrossMarkDomains[1]: elsevier.com
pdf:docinfo:subject: YNICL, 3 (2013) 84-94. doi:10.1016/j.nicl.2013.07.005
pdf:docinfo:creator: Juergen Dukart
meta:author: Karsten Mueller
meta:creation-date: 2013-12-08T22:41:56Z
pdf:docinfo:custom:CrossmarkMajorVersionDate: 2010-04-23
created: 2013-12-08T22:41:56Z
access_permission:extract_for_accessibility: true
Creation-Date: 2013-12-08T22:41:56Z
pdf:docinfo:custom:CrossMarkDomains[2]: sciencedirect.com
ElsevierWebPDFSpecifications: 6.2
pdf:docinfo:custom:doi: 10.1016/j.nicl.2013.07.005
pdf:docinfo:custom:CrossmarkDomainExclusive: true
Author: Karsten Mueller
producer: Acrobat Distiller 10.0.0 (Windows)
CrossmarkDomainExclusive: true
pdf:docinfo:producer: Acrobat Distiller 10.0.0 (Windows)
doi: 10.1016/j.nicl.2013.07.005
pdf:unmappedUnicodeCharsPerPage: 0
dc:description: YNICL, 3 (2013) 84-94. doi:10.1016/j.nicl.2013.07.005
Keywords: "Ageing;  Alzheimer's disease;  [18F]fluorodeoxyglucose positron emission tomography (FDG-PET);  Magnetic resonance imaging (MRI);  Mild cognitive impairment"; Ageing; Alzheimer's disease; "[18F]fluorodeoxyglucose positron emission tomography (FDG-PET)"; Magnetic resonance imaging (MRI); Mild cognitive impairment
access_permission:modify_annotations: true
dc:creator: Karsten Mueller
description: YNICL, 3 (2013) 84-94. doi:10.1016/j.nicl.2013.07.005
dcterms:created: 2013-12-08T22:41:56Z
Last-Modified: 2014-07-28T07:29:01Z
dcterms:modified: 2014-07-28T07:29:01Z
title: Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease
xmpMM:DocumentID: uuid:c142d30b-02a8-4938-bee7-5401a30ff853
Last-Save-Date: 2014-07-28T07:29:01Z
CrossMarkDomains[1]: elsevier.com
pdf:docinfo:keywords: "Ageing;  Alzheimer's disease;  [18F]fluorodeoxyglucose positron emission tomography (FDG-PET);  Magnetic resonance imaging (MRI);  Mild cognitive impairment"; Ageing; Alzheimer's disease; "[18F]fluorodeoxyglucose positron emission tomography (FDG-PET)"; Magnetic resonance imaging (MRI); Mild cognitive impairment
pdf:docinfo:modified: 2014-07-28T07:29:01Z
meta:save-date: 2014-07-28T07:29:01Z
Content-Type: application/pdf
X-Parsed-By: org.apache.tika.parser.DefaultParser
creator: Karsten Mueller
dc:subject: "Ageing;  Alzheimer's disease;  [18F]fluorodeoxyglucose positron emission tomography (FDG-PET);  Magnetic resonance imaging (MRI);  Mild cognitive impairment"; Ageing; Alzheimer's disease; "[18F]fluorodeoxyglucose positron emission tomography (FDG-PET)"; Magnetic resonance imaging (MRI); Mild cognitive impairment
pdf:docinfo:custom:ElsevierWebPDFSpecifications: 6.2
access_permission:assemble_document: true
xmpTPg:NPages: 11
pdf:charsPerPage: 4687
access_permission:extract_content: true
access_permission:can_print: true
CrossMarkDomains[2]: sciencedirect.com
meta:keyword: "Ageing;  Alzheimer's disease;  [18F]fluorodeoxyglucose positron emission tomography (FDG-PET);  Magnetic resonance imaging (MRI);  Mild cognitive impairment"; Ageing; Alzheimer's disease; "[18F]fluorodeoxyglucose positron emission tomography (FDG-PET)"; Magnetic resonance imaging (MRI); Mild cognitive impairment
access_permission:can_modify: true
pdf:docinfo:created: 2013-12-08T22:41:56Z
CrossmarkMajorVersionDate: 2010-04-23